# Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

> **NCT00792753** · NA · COMPLETED · sponsor: **Elixir Medical Corporation** · enrollment: 360 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Medtronic Endeavor Coronary Stent System
- **DEVICE:** DESyne BD Novolimus Stent System
- **DEVICE:** DESyne Novolimus Stent System

## Key facts

- **NCT ID:** NCT00792753
- **Lead sponsor:** Elixir Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-11
- **Final completion:** 2014-03-08
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2020-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00792753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00792753, "Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00792753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*